Effect of a Quality Improvement Bundle to Standardize the Use of Intravenous Fluids for Hospitalized Pediatric

Sahar N Rooholamini1, Brittany Jennings2, Chuan Zhou1,3

  • 1Department of Pediatrics, University of Washington, Seattle.

JAMA Pediatrics
|November 15, 2021
PubMed

Insights

A quality improvement intervention increased the use of isotonic maintenance intravenous fluids (IVF) in pediatric hospitals. The intervention did not increase adverse events or laboratory testing, but further efforts are needed to reduce unnecessary lab tests.

Area of Science:

  • Pediatric hospital quality improvement
  • Intravenous fluid management
  • Clinical practice guideline implementation

Background:

  • Hypotonic maintenance intravenous fluids (IVF) may cause hospital-acquired harm.
  • The American Academy of Pediatrics recommends isotonic IVF for pediatric patients.
  • Unnecessary laboratory tests contribute to healthcare waste and patient harm.

Purpose of the Study:

  • To evaluate a quality improvement intervention bundle's effect on increasing exclusive isotonic IVF use.
  • To assess the intervention's impact on decreasing laboratory tests obtained during hospitalization.

Main Methods:

  • A stepped-wedge, cluster randomized clinical trial (Standardization of Fluids in Inpatient Settings [SOFI]) involving 106 US pediatric hospitals.
  • Intervention components included educational materials, a clinical algorithm, electronic medical record interventions, and "harms of overtesting" cards.
  • Outcomes were analyzed using linear mixed-effects regression models, comparing baseline and intervention periods.

Main Results:

  • The intervention bundle led to a 5.4% absolute increase in exclusive isotonic IVF use.
  • No significant change was observed in the proportion of hospital days with laboratory test values obtained (0.1% difference).
  • There was a 4.4% increase in daily patient weight measurements while receiving IVF, with no increase in adverse events or electrolyte testing.

Conclusions:

  • The intervention effectively improved isotonic maintenance IVF use in pediatric settings.
  • The study highlights the need for further strategies to deimplement unnecessary laboratory testing.
  • The findings support the adoption of evidence-based practices to enhance patient safety and reduce healthcare waste.
Abstract

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
68
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
82
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
159
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
317
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
24